| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 3,923,817 | 3,771,461 | 4,137,107 | 4,468,687 | | Cost of Revenue | 555,579 | 631,848 | 684,756 | 624,319 | | | Gross Profit | 3,368,238 | 3,139,613 | 3,452,351 | 3,844,368 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,878,382 | 1,727,465 | 1,894,228 | 1,794,900 | | Non Recurring | 53,768 | 17,627 | 863,715 | 15,306 | | Others | 901,139 | 1,312,036 | 2,098,921 | 1,093,917 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 534,949 | 82,485 | (1,404,513) | 940,245 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 534,949 | 82,485 | (1,404,513) | 940,245 | | Interest Expense | 212,470 | 229,629 | 281,668 | 340,832 | | Income Before Tax | 322,479 | (147,144) | (1,686,181) | 599,413 | | Income Tax Expense | 92,278 | (60,223) | (289,856) | 213,624 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 230,201 | (86,921) | (1,396,325) | 385,789 | | | Non-recurring Events | | Discontinued Operations | (5,998) | (24,958) | (25,221) | (11,650) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 224,203 | (111,879) | (1,421,546) | 374,139 | | Preferred Stock And Other Adjustments | (563,908) |
-
| (32,723) |
-
| | | Net Income Applicable To Common Shares | ($339,705) | ($111,879) | ($1,454,269) | $374,139 |
|
2.03% Nasdaq 
Income Statement
